Literature DB >> 9213170

Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients.

M Nakagawa1, T Matsuzaki, I Higuchi, H Fukunaga, T Inui, S Nagamitsu, H Yamada, K Arimura, M Osame.   

Abstract

We studied 71 Japanese individuals, 42 patients (30 familial and 12 sporadic) suspected to have facioscapulohumeral muscular dystrophy (FSHD) and 29 family members, clinically and genetically using the chromosome 4qter DNA marker p13E-11. Early onset FSHD was detected in 7 patients, tortuosity of retinal arterioles and hearing impairment in 3 patients, progressive respiratory failure in 3 patients and limb-girdle type muscular weakness in 6 patients. Thirty-six (85.7%) FSHD patients, 3 asymptomatic family members and 1 of 35 healthy volunteers showed EcoRI digestion fragments shorter than 28kb. New mutations were detected in 25% of the patients with shorter EcoRI fragment. The age of disease onset appeared younger with successive generations in 6 parent-child pairs in FSHD families. We confirmed the existence of phenotypic and genetic diversities in Japanese patients with FSHD. It is still difficult to explain the phenotypic diversity merely by the size of the abnormal EcoRI fragment detected with the p13E-11 probe.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213170     DOI: 10.2169/internalmedicine.36.333

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Facioscapulohumeral Muscular Dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Continuum (Minneap Minn)       Date:  2016-12

2.  Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.

Authors:  Dalila Laoudj-Chenivesse; Gilles Carnac; Catherine Bisbal; Gerald Hugon; Sandrine Bouillot; Claude Desnuelle; Yegor Vassetzky; Anne Fernandez
Journal:  J Mol Med (Berl)       Date:  2004-11-17       Impact factor: 4.599

3.  Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size.

Authors:  Jeffrey M Statland; Sabrina Sacconi; Constantine Farmakidis; Colleen M Donlin-Smith; Mina Chung; Rabi Tawil
Journal:  Neurology       Date:  2013-02-27       Impact factor: 9.910

Review 4.  Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals.

Authors:  Ceren Hangül; Sibel Berker Karaüzüm; Esra Küpeli Akkol; Devrim Demir-Dora; Zafer Çetin; Eyüp İlker Saygılı; Gökhan Evcili; Eduardo Sobarzo-Sánchez
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

5.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

Review 6.  Does DNA Methylation Matter in FSHD?

Authors:  Valentina Salsi; Frédérique Magdinier; Rossella Tupler
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

7.  Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice.

Authors:  Sachchida N Pandey; Jennifer Cabotage; Rongye Shi; Manjusha Dixit; Margret Sutherland; Jian Liu; Stephanie Muger; Scott Q Harper; Kanneboyina Nagaraju; Yi-Wen Chen
Journal:  Biol Open       Date:  2012-05-25       Impact factor: 2.422

8.  Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.

Authors:  Ana Nikolic; Giulia Ricci; Francesco Sera; Elisabetta Bucci; Monica Govi; Fabiano Mele; Marta Rossi; Lucia Ruggiero; Liliana Vercelli; Sabrina Ravaglia; Giacomo Brisca; Chiara Fiorillo; Luisa Villa; Lorenzo Maggi; Michelangelo Cao; Maria Chiara D'Amico; Gabriele Siciliano; Giovanni Antonini; Lucio Santoro; Tiziana Mongini; Maurizio Moggio; Lucia Morandi; Elena Pegoraro; Corrado Angelini; Antonio Di Muzio; Carmelo Rodolico; Giuliano Tomelleri; Maria Grazia D'Angelo; Claudio Bruno; Angela Berardinelli; Rossella Tupler
Journal:  BMJ Open       Date:  2016-01-05       Impact factor: 2.692

9.  Assessment of diaphragm motion using ultrasonography in a patient with facio-scapulo-humeral dystrophy: A case report.

Authors:  Abdallah Fayssoil; Tanya Stojkovic; Adam Ogna; Pascal Laforet; Helene Prigent; Frederic Lofaso; David Orlikowski; Guillaume Bassez; Bruno Eymard; Anthony Behin
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

10.  Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.

Authors:  Ana Nikolic; Takako I Jones; Monica Govi; Fabiano Mele; Louise Maranda; Francesco Sera; Giulia Ricci; Lucia Ruggiero; Liliana Vercelli; Simona Portaro; Luisa Villa; Chiara Fiorillo; Lorenzo Maggi; Lucio Santoro; Giovanni Antonini; Massimiliano Filosto; Maurizio Moggio; Corrado Angelini; Elena Pegoraro; Angela Berardinelli; Maria Antonetta Maioli; Grazia D'Angelo; Antonino Di Muzio; Gabriele Siciliano; Giuliano Tomelleri; Maurizio D'Esposito; Floriana Della Ragione; Arianna Brancaccio; Rachele Piras; Carmelo Rodolico; Tiziana Mongini; Frederique Magdinier; Valentina Salsi; Peter L Jones; Rossella Tupler
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.